Principal Financial Group
WVE icon

Principal Financial Group’s Wave Life Sciences WVE Stock Holding History

Principal Financial Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-170,170
Closed -$2.89M – 2298
2025
Q4 		$2.89M Buy
+170,170
New +$1.73M ﹤0.01% 1774
2025
Q3 		– Sell
-302,276
Closed -$1.96M – 2349
2025
Q2 		$1.96M Sell
302,276
-5,768
-2% -$38.1K ﹤0.01% 1805
2025
Q1 		$2.49M Buy
308,044
+59,399
+24% +$650K ﹤0.01% 1734
2024
Q4 		$3.08M Buy
+248,645
New +$3.32M ﹤0.01% 1718
2024
Q3 		– Sell
-14,766
Closed -$73.7K – 2416
2024
Q2 		$73.7K Buy
+14,766
New +$84.2K ﹤0.01% 2246

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Principal Financial Group's WVE Position: Q1 2026 in Review

Principal Financial Group sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 170,170 shares — an estimated $2.89M sold.

Principal Financial Group first reported a position in WVE in Q2 2024 and held it in 5 quarters. The position peaked at $3.08M in Q4 2024. 232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Principal Financial Group reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Principal Financial Group sold 170,170 Wave Life Sciences shares in Q1 2026, an estimated $2.89M.
  • Principal Financial Group first reported a position in Wave Life Sciences in Q2 2024 and held it in 5 quarters.
  • Principal Financial Group's Wave Life Sciences position peaked at $3.08M in Q4 2024.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.